Last updated: August 30, 2022
Sponsor: Cairo University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Open Heart Surgery
Treatment
N/AClinical Study ID
NCT05522712
P.T.REC/012/003310
Ages 30-40 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients of both sexes with age ranges (30-40) years old.
- Patients with normal body mass index ranges (18.5-24.9) kg/m2
- Patients undergo mitral valve surgery via median sternotomy.
- Post operative, extubated heart valve surgery patients, who were able to follow theinstructions and sign the consent form.
- Patients with hemodynamic stability.
- Patients with controlled diabetes mellitus.
Exclusion
Exclusion Criteria:
- Patients who required more than 48 hours of intubation after surgery.
- Reintubation in post operative period.
- Patients who had history of respiratory tract infection within a period of threemonths.
- Patients undergo CABG ,or double valve surgery.
- Patients with any neuromuscular disease.
- Patients with severe renal dysfunction.
- Anemic patients.
- Uncontrolled diabetes mellitus.
Study Design
Total Participants: 60
Study Start date:
January 01, 2022
Estimated Completion Date:
March 30, 2023
Study Description
Connect with a study center
Faculty of physical therapy
Giza, Dokki 12613
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.